Stock FRLN FREELINE THERAPEUTICS HOLDINGS PLC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Sector Chart Freeline Therapeutics Holdings plc

Equities

FRLN

US35655L2060

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 104B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 97.47B
ARGENX SE Stock argenx SE
 22.25B -
BIONTECH SE Stock BioNTech SE
 21.68B -
GENMAB A/S Stock Genmab A/S
 18.2B
  1. Stock Market
  2. Equities
  3. FRLN Stock
  4. Charts Freeline Therapeutics Holdings plc
  5. Sector Chart